EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer’s Disease

Paola Gualtieri iD, Giulia Frank iD, Rossella Cianci iD, Lucilla Ciancarella, Leonardo Romano, Moreno Ortoman, Giulia Bigioni, Francesco Nicoletti, Mario Isidoro Falco, Giada La Placa iD, Laura Di Renzo iD

Nutrients · 06.03.2025 · 17 (5) · 922

DOI: 10.3390/nu17050922 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 06.03.2025. Verfasst von Paola Gualtieri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Clinical Nutrition and Nutrigenomics, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Dietary Supplements. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health within the PNRR Mission 6 initiative on Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer’s disease (AD) represents one of the major challenges of modern medicine, with a growing impact on public health and healthcare systems. In recent years, dietary supplements use has been the subject of increasing interest as a complementary strategy for the prevention and treatment of the disease. Materials and Methods: A Review of reviews was conducted following PRISMA guidelines and REAPPRAISED checklist to evaluate the efficacy and safety of supplement use in AD. The search, performed across major scientific databases, identified 54 relevant articles, including 53 reviews and one mini-review, after applying specific inclusion criteria and removing duplicates.

Results

The growing body of evidence suggests that some supplements may help reduce cognitive decline, inflammation, and target mechanisms behind AD. However, many of these supplements are still under investigation, with mixed results highlighting the need for high-quality research. A key challenge is the lack of data on optimal dosages, administration duration, and long-term safety, which limits clinical guidelines. Some studies have reported positive effects from specific regimens, such as curcumin (800 mg/day), omega-3 fatty acids (2 g/day), and resveratrol (600 mg/day). Other supplements, like phosphatidylserine (300 mg/day), multinutrient formulations, probiotics, vitamin E (2000 IU/day), and melatonin (3–10 mg/day), also show benefits, though study variability makes conclusions uncertain.

Conclusions

While certain supplements show potential in mitigating cognitive decline in AD, inconsistent findings and gaps in dosage and safety data highlight the need for rigorous, large-scale trials. Future research should focus on personalized, multimodal strategies integrating targeted supplementation, dietary patterns, and microbiota-gut-brain interactions for enhanced neuroprotection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDietary SupplementsHumansFatty Acids, Omega-3ProbioticsTreatment Outcome

Stichwörter der Autor:innen

Alzheimer’s diseasemicrobiotapersonalized nutritionsupplements efficacy and safety

Substanzen

Fatty Acids, Omega-3

Autor:innen und Institutionen

  • Section of Clinical Nutrition and Nutrigenomics, Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • School of Specialization in Food Sciences, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • PhD School of Applied Medical-Surgical Sciences, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy.
  • Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.

ORCID-Profile: Paola Gualtieri, Giulia Frank, Rossella Cianci, Giada La Placa, Laura Di Renzo

Förderung

  • Ministero della Salute
  • Italian Ministry of Health within the PNRR Mission 6 initiative on Health

Zitieren

APA

Gualtieri, P., Frank, G., Cianci, R., Ciancarella, L., Romano, L., Ortoman, M., Bigioni, G., Nicoletti, F., Falco, M. I., La Placa, G., & Di Renzo, L. (2025). Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer’s Disease. Nutrients, 17(5), 922. https://doi.org/10.3390/nu17050922

Vancouver

Gualtieri P, Frank G, Cianci R, Ciancarella L, Romano L, Ortoman M, et al. Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer’s Disease. Nutrients. 2025;17(5):922. doi:10.3390/nu17050922

BibTeX
@article{Gualtieri2025,
  author = {Gualtieri, Paola and Frank, Giulia and Cianci, Rossella and Ciancarella, Lucilla and Romano, Leonardo and Ortoman, Moreno and Bigioni, Giulia and Nicoletti, Francesco and Falco, Mario Isidoro and La Placa, Giada and Di Renzo, Laura},
  title = {Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer’s Disease},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {922},
  doi = {10.3390/nu17050922}
}
Kostenlos starten →